CELLUSION focuses on corneal treatment using cell transplantation derived from iPS cells. The company is engaged in research and development in the field of regenerative medicine.
investor of
Metrics
marketPRIVATE
msh_idJP:CELLUSION
localejp
websitehttps://cellusion.jp
source_ref66be92dd-def2-4fb3-ae5b-0202137caeaf
products_or_servicesCorneal treatment and research using iPS cell-based cell transplantation.
Japan